Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 29, 2023

Litigation Details for Route1 Inc. v. AirWatch LLC (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Route1 Inc. v. AirWatch LLC (D. Del. 2017)

Docket	⤷ Try a Trial	Date Filed	2017-03-27
Court	District Court, D. Delaware	Date Terminated	2019-10-07
Cause	28:1338 Patent Infringement	Assigned To	Kent A. Jordan
Jury Demand	Plaintiff	Referred To
Parties	AIRWATCH LLC; ROUTE1 INC.; VMWARE, INC.
Patents	6,695,722; 7,981,905; 8,562,979; 8,562,981; 8,642,858; 8,858,987; 8,905,979; 8,987,554; 9,572,814; 9,814,722; 9,987,285
Attorneys	Aaron M. Williams; Anne Shea Gaza; Bita Rahebi; Christine E. Duh; Christopher J. Wiener; Cynthia D. Vreeland; Dana O. Burwell; Dominick T. Gattuso; Elena C. Norman; Elizabeth Ann Patterson; Marcel C. Duhamel; Michael H. Smith; Michael J. Garvin; Peter M. Dichiara; Rex W. Miller; Richard S.J. Hung; Samantha G. Wilson; William F. Lee; William H. Oldach
Firms	Heyman Enerio Gattuso & Hirzel LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Route1 Inc. v. AirWatch LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Biologic Drugs cited in Route1 Inc. v. AirWatch LLC

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for Route1 Inc. v. AirWatch LLC (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-04-23	334	Opinion - Memorandum Opinion	a flat hourly rate for all attorneys of $695 in 2018 and $722 in 2019. That is a reasonable rate for … asserted infringement of U.S. Patent No. 7,814,216 (the “’216 patent”). After I construed disputed …infringement claim, “the technology described in the ’216 patent is directed to a means for remote computing access…communication network. (’216 Pat. 1:7-10.) The ’216 patent claims a method by which users of ‘remote devices…the “instruction limitation,” of claim 1 of the patent. That limitation states that the controller sends	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Mallinckrodt

AstraZeneca

Express Scripts

Merck

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.